GLP-1 and incretin peptides are the most-researched class in metabolic science. They act on incretin receptors — GLP-1, GIP, and glucagon — studied in glycemic, metabolic, and appetite-regulation research.
The compounds
- Semaglutide — GLP-1 receptor agonist (overview)
- Tirzepatide — dual GIP/GLP-1 agonist (overview)
- Retatrutide — triple GIP/GLP-1/glucagon agonist (overview)
- Cagrilintide — long-acting amylin analog
How they compare
Single vs dual vs triple receptor targets are the key research distinction — see Tirzepatide vs Semaglutide and Retatrutide vs Tirzepatide. Amylin and GLP-1 are also co-studied in the Cagrilintide + Semaglutide blend.
Why researchers buy from Miami Peptide Lab
- Independently tested every lot — every Certificate of Analysis published in full
- Ships from Miami / the US in 24–48h, discreet cold-chain packaging
- Bundle savings and a reship-or-refund guarantee
Research Use Only. Sold strictly for laboratory research — not for human or animal consumption, nor for therapeutic, diagnostic, or cosmetic use.
